Immunotherapy in CRC Depends on Identifying Predictive Biomarkers – Targeted Oncology
Targeted Oncology |
Immunotherapy in CRC Depends on Identifying Predictive Biomarkers
Targeted Oncology “There are studies in the first line as well as the adjuvant setting, but we do not have data on those studies. We are starting to see broader testing of solid tumor types in mismatch repair by immunohistochemistry and polymerase chain reaction. We're … |
